• 6045 Citations
  • 43 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 6045 Citations
  • 43 h-Index
  • 160 Article
  • 8 Review article
  • 2 Comment/debate
  • 2 Letter

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases

Flørenes, V. A., Flem-Karlsen, K., McFadden, E., Bergheim, I. R., Nygaard, V., Nygård, V., Farstad, I. N., Øy, G. F., Emilsen, E., Giller-Fleten, K., Ree, A. H., Flatmark, K., Gullestad, H. P., Hermann, R., Ryder, T., Wernhoff, P. & Mælandsmo, G. M., Jul 1 2019, In : Translational Oncology. 12, 7, p. 951-958 8 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
Lymph Nodes
Neoplasm Metastasis
Mutation
Neoplasms

Breast cancer quantitative proteome and proteogenomic landscape

Consortia Oslo Breast Cancer Research Consortium (OSBREAC), Dec 1 2019, In : Nature communications. 10, 1, 1600.

Research output: Contribution to journalArticle

Open Access
proteome
Proteome
breast
Tumors
tumors
1 Citation (Scopus)

Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft

Fusser, M., Overbye, A., Pandya, A. D., Mørch, Ý., Borgos, S. E., Kildal, W., Snipstad, S., Sulheim, E., Fleten, K. G., Askautrud, H. A., Engebraten, O., Flatmark, K., Iversen, T. G., Sandvig, K., Skotland, T. & Mælandsmo, G. M., Jan 10 2019, In : Journal of Controlled Release. 293, p. 183-192 10 p.

Research output: Contribution to journalArticle

Cyanoacrylates
Heterografts
Nanoparticles
Breast Neoplasms
Pharmaceutical Preparations

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

Camilio, K. A., Wang, M. Y., Mauseth, B., Waagene, S., Kvalheim, G., Rekdal, Ø., Sveinbjørnsson, B. & Mælandsmo, G. M., Jan 22 2019, In : Breast Cancer Research. 21, 1, 9.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Doxorubicin
Carcinogenesis
Peptides
Health

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer

Grinde, M. T., Hilmarsdottir, B., Tunset, H. M., Henriksen, I. M., Kim, J., Haugen, M. H., Rye, M. B., Mælandsmo, G. M. & Moestue, S. A., May 14 2019, In : Breast Cancer Research. 21, 1, 61.

Research output: Contribution to journalArticle

Open Access
Glutaminase
Glutamine
Proline
Immunohistochemistry
Breast Neoplasms